CleanSpace Holdings Limited (ASX: CSX) - Share Price
Current share price for CSX : $0.450 0.02 (4.26%)+
CleanSpace Holdings Limited (CSX) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is engaged in design, manufacture and sale of respirators and related products and services. The Company's respirator solutions use patented technology and miniaturisation design (collectively called AirSensit) that improve personal respiratory protection against dust, biological and gas airborne hazards.
CSX General Information +
| ASX Code | CSX |
| Website | http://www.cleanspacetechnology.com |
| Industry/Sector | Health Care Equipment |
| Market Cap ($M) | 35 |
| CSX Share Price | $0.450 |
| Day High | $0.470 |
| Day Low | $0.450 |
| Last Close | $0.470 |
| CSX Share Price Movement | $0.02 ( 4.26% ) |
Prices as at 16:40, 30 Oct 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
CleanSpace Holdings Limited (CSX) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from CleanSpace Holdings Limited (CSX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
CleanSpace Holdings Limited (CSX) price-sensitive announcements
CSX - FY26 Results Announcement
CleanSpace Holdings Limited announced its FY26 audited results, reporting resilient revenu
CleanSpace Holdings Limited (CSX)
28 Aug 2026 | 9:12 AM
28 Aug 2026 | 9:12 AM
CSX - Appendix 4E and Annual Report
CleanSpace Holdings Limited’s Appendix 4E and Annual Report for the year ended 30 June 202
CleanSpace Holdings Limited (CSX)
28 Aug 2026 | 9:03 AM
28 Aug 2026 | 9:03 AM
CSX - On-market Share Buyback
CleanSpace Holdings Limited announced an on-market share buy-back of up to 10% of its issu
CleanSpace Holdings Limited (CSX)
28 Aug 2026 | 8:44 AM
28 Aug 2026 | 8:44 AM
CSX - CleanSpace Secures A$1.9 million in New Orders
CleanSpace Holdings Limited, an Australian company, announced securing a significant order
CleanSpace Holdings Limited (CSX)
10 Aug 2026 | 8:42 AM
10 Aug 2026 | 8:42 AM
CleanSpace Holdings Limited (CSX) Recent ASX Announcements
CSX Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026A | -$4.08 | -$5.20 | -1,953.60% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2025A | $0.22 | $0.30 | -106.90% | 154.20 | 0.00 | 0.00% | 0.0% |
| 2024A | -$3.13 | -$4.10 | -61.70% | 0.00 | 0.00 | 0.00% | 0.0% |
CSX Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | ||
| Cochlear Limited (COH) | $9,300M | -0.3136 | 0.2540 | 0.0785 | 34.6196 | 27.6074 | 25.5981 | 2.43% | 2.52% | 2.74% |
| CleanSpace Holdings Limited (CSX) | $37M | -19.5357 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Fisher & Paykel Healthcare Corporation Limited (FPH) | $22,266M | 0.1388 | 0.1446 | 0.1574 | 57.2357 | 50.0066 | 43.2078 | 1.15% | 1.24% | 1.38% |
| Imricor Medical Systems Inc (IMR) | $466M | -0.4254 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| ResMed Inc. (RMD) | $20,171M | 9.5922 | 0.1012 | 0.0991 | 22.9725 | 20.8621 | 18.9817 | 1.01% | 1.10% | 1.20% |
CSX Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 1.93 | 0.00 |
| Market | 0.30 | 13.20 | 1.03 | 0.74 |
| Sector | 0.72 | 21.90 | 1.74 | 2.48 |
CSX Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Dan Kao | Director-Operations & Founder, Executive Director | 1 Apr 2011 |
| Mr Graham McLean | Executive Director, Executive Chairman | 1 Feb 2022 |
| Ms Lisa Ray Hennessy | Non-Executive Director | 9 Dec 2021 |
| Mr Paul Cassano | Non-Executive Director | 1 Sep 2023 |
CleanSpace Holdings Limited (CSX) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 7 Oct 2026 | CASSANO, Paul | Buy | Direct Shares | 10,000 | $0.502 | $5,019.950 |
| 30 Sep 2026 | CASSANO, Paul | Buy | Direct Shares | 50,000 | $0.440 | $21,999.360 |
| 9 Mar 2026 | MCLEAN, Graham | Buy | Indirect Shares | 59,984 | $0.519 | $31,148.610 |
See all changes in directors' interest & trades for CleanSpace Holdings Limited (CSX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
CSX Management
| Name | Position |
|---|---|
| Bree Greeff | CFO |
| Gabrielle O'Carroll | Chief Executive Officer |
| Elissa Hansen | Company Secretary |
CSX Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in CleanSpace Holdings Limited (CSX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 10,591,669 (13.35%) | Jencay Capital Pty Limited |
| 9,257,535 (11.66%) | One Fund Services Ltd |
| 4,163,550 (5.26%) | Acorn Capital Limited |
CSX Calendar of Events
| Date | Event |
|---|---|
| 27 August 2027 | Report (Annual) |
| 27 August 2027 | Report (Prelim) |
| 25 February 2027 | Report (Interim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
